DIA 2021 Global Annual Meeting

Back to Agenda

Electronic Labeling: Where are we Now and What are the Next Steps in the World?

Session Chair(s)

Rie Matsui, RPh

Senior Director, Regional Labeling Head for APAC, International Labeling

Pfizer R&D Japan G.K., Japan

The most updated eLabeling initiatives in the US, EU, Canada, and Japan, and the trends for eLabeling in emerging markets will be shared. The possibility of the convergence of the eLabeling initiatives will be discussed in the digital health.v

Learning Objective : Describe the most updated electronic labeling initiatives in the US, EU, Canada, Japan, and emerging countries; Discuss the possibility of the convergence for electronic labeling across regions.

Speaker(s)

eLabeling Updates in Japan and Collaboration with Asia Countries

Shinobu Uzu, PhD

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Senior Executive Director

Electronic Product Information (ePI) in the EU: Progress and the Road Ahead

Elizabeth Scanlan, PhD, MSc

European Medicines Agency, Netherlands

ePI Product Owner

Behind the Scenes in Implementing eLabeling: COVID-19 Vaccine Label Development During a Global Pandemic

Christine Wood, PhD

AstraZeneca, United Kingdom

Global Labeling TA Director (Respiratory and Immunology)

Have an account?